To identify the active molecule in human alpha interferon preparations, we performed several studies, using both partially purified interferon and homogeneous interferon. Our results indicated that there is little difference between the partially purified and the homogeneous interferon preparations in terms of antiviral activity, inhibition of deoxyribonucleic acid synthesis in human neoplastic celis, and enhancement of human natural killer cell activity.
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Interferons (IFNs) are a group of small glycoproteins that exhibit many immunomodulatory, antiviral, and antitumor effects in vivo and in vitro (7, 9, 14, 19) . Their production may be induced in any vertebrate cell by viruses and double-stranded ribonucleic acid (RNA) or in lymphoid cells by mitogens (20) . There are three types of classical IFNs: leukocyte (IFN-a), fibroblast (IFN-fi), and lymphoblastoid (IFN-a).
These are differentiated by their cell source, antigenicity, and amino acid sequences (8, 17, 23, 24) .
Homogeneous preparations of IFNs have just recently become available in small quantities (10, 15, 16, 24) . Electrophoretically pure mouse IFN with a specific activity of approximately 109 U/mg of protein (molecular weights, 35,000 and 22,000) has been isolated and tested in vivo and in vitro (10) . It has been demonstrated that the pure IFN has biological characteristics similar to crude or partially purified (PP) fractions with specific activities ranging from 1 x 107 to 2.9 x 107 mouse IFN U/mg of protein used in previous investigations.
Because of the modifications of techniques for large-scale production and biochemical purification (1, 6), a component of human IFN-a [IFN-a(Ly)], with an apparent molecular weight of 18,500, has also been recently purified to homogeneity (2.5 x 108 U/mg of protein) (23, 24) . New advances in analyses by high-performance liquid chromatography and microsequencing have permitted the composition and sequence determinations of this IFN molecule and other mouse and human types (13, 17, (21) (22) (23) 1 ,uCi/20,ul; 1.9 Ci/mmol) was added immediately, and cultures were incubated for another 16 h. Subsequently, cultures were processed with a multiple automated sample harvester (3) .
Treatment of neoplastic human cell lines with 2.5 to 2,500 U of PP human IFN-a(Ly) per culture resulted in significant levels of inhibition ofDNA synthesis as measured by [3H]thymidine uptake ( Table 1) . Levels of inhibition as high as 45, 50, and 61% were found when K562, Daudi (data not shown), and U937 cell lines, respectively, were treated with 2,500 U of IFN. Similar - Both clinical and experimental tials with PP IFN preparations have indicated that its putative antitumor effects derive from a number of immunomodulatory changes that occur with IFN-treated immune and tumor cells (20) . In addition to suppressing tumor cell growth, IFNs can apparently augment the effectiveness of tumor surveillance and rejection systems (3-5, 10, 12) . Additional effects, such as the suppression (Daudi) .
The finding that the various biological properties previously attributed to PP-IFN preparations are also common to H IFN provides strong evidence that the single molecule present in the H fraction is responsible for both the described inhibitory and immunoregulatory actions of IFN. More studies with homogeneous preparations of this IFN are needed to reveal the true nature of this molecule and its mechanism of action.
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